LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$29.34
1.41 (5.05%)
▲
5d:
-18.2%
30d:
+4.34%
90d:
+68.52%
WAIT
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LEGN is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LEGN is down 18.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$63.32
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$39.32
25.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $29.34, which is considered fair relative to its 30-day fair value range of $27.50 to $34.45. From a valuation perspective, the stock is trading at a discount (Forward PE: 22.6) compared to its historical average (38.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a strong uptrend. Immediate support is located at $27.43, while resistance sits at $36.85. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.59 (+96.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEGN is in a strong uptrend. Immediate support is located at $27.43, while resistance sits at $36.85. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $57.59 (+96.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$27.50 -
$34.45
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 96.3% below Wall St target ($57.59)
- WARNING: Recommendation downgraded due to -18.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$27.50 -
$34.45
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$27.43
Resistance Level
$36.85
Current Trend
Strong Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.56
Wall Street Target
$57.59
(+96.3%)
Revenue Growth (YoY)
56.5%
Profit Margin
-22.0%
Valuation Discount vs History
-16.1% cheaper
PE vs Historical
22.6 vs 38.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.1%
(market-implied from PE analysis)
1-Year Target
$26.41
(-10%)
2-Year Target
$23.77
(-19%)
3-Year Target
$21.39
(-27%)
3-Yr Target (if PE normalizes)
(PE: 23→38)
$36.32
(+24%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.6, Growth: 364.5%)
$99.02
(+238%)
Base:
(SPY PE: 21.8, Growth: 364.5%)
$95.61
(+226%)
Bear:
(PE: 18.5, Growth: 364.5%)
$81.27
(+177%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 22.6 to 38.3
Stabilization Target:
$49.82
(+69.8%)
PE Expansion Potential:
+69.8%
Share & Embed Analysis
Last updated: June 23, 2026 7:50 AM ET
Data refreshes hourly during market hours. Next update: 8:50 AM
Data refreshes hourly during market hours. Next update: 8:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 69 BUY |
